ArticleJournal of comparative effectiveness research2025

Overall survival in patients with metastatic castration-sensitive prostate cancer treated with apalutamide versus abiraterone acetate: a head-to-head analysis of real-world patients in the USA.

Benjamin Lowentritt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.